Bli medlem
Bli medlem

Du är här


Datawatch Corporation: Binding Site Slashes Production Time and Saves Hundreds of Thousands of Dollars With Datawatch Self-Service Data Preparation

BEDFORD, Mass., Jan. 19, 2016 (GLOBE NEWSWIRE) -- Binding Site, the world
leader in special protein diagnostics, is saving hundreds of man-hours daily
and hundreds of thousands of dollars annually automating data processing in
its research using data preparation software from Datawatch Corporation

Binding Site supplies the world's laboratories with clinical diagnostic tools
to diagnose and monitor specific cancers and immune disorders. During
production, it must constantly analyze the results of its scientific
instruments while producing a meticulous audit trail of data to comply with
FDA regulations.

The company used to have to re-key test results from print-outs generated by
its scientific laboratory instruments into a spreadsheet, manually correcting
and verifying each entry before the results could be officially vetted and
archived. Since Binding Site runs approximately 155 experiments per day
across 40 machines, data processing had become an enormous and costly

"The process was laborious and cumbersome, requiring on average two man-hours
per experiment, which is time that could be saved," said Dr. Adeel Mushtaq,
Head of Production Control at Binding Site.

When Binding Site recently modernized its business operations with a new ERP
system, Ian Rocky the IT Manager saw an opportunity to apply Datawatch's
self-service data preparation technology to save time and meet requirements.

Datawatch pulls in data from a wide range of unstructured and multi-structured
data formats like PDF, XML, HTML, text, spool and ASCII files that are
typically too challenging to integrate into analytical applications. Binding
Site uses Datawatch to automate the reading of PDF output files captured by
the ERP system from the instrumentation, identifying fields and updating an
Oracle database.

Long term, by eliminating manual data preparation processes, Binding Site will
save greater than $600,000 annually by reducing labor time alone in addition
to improving data workflow.

"And beyond the time and cost savings, Datawatch has accelerated our ability
to gather data. Our business processes will be improved thanks to our ability
to automate the capture of instrument data, speed the flow of business
information, and meet quality&regulatory requirements much more easily,"
Mushtaq added.

"Binding Site is the perfect example of how organizations can drive
efficiencies, save money and improve regulatory compliance and auditing with
automation. While other companies spend up to 80 percent of their analysts'
time on data preparation, typically with many errors, Binding Site is
quickly transforming raw information into reliable, consistent data sets
ready for data analysis and reporting," said Dan Potter, chief marketing
officer at Datawatch.

About Binding Site

Binding Site is committed to improving patient lives worldwide through
education, collaboration and innovation. The company focuses on research,
development, manufacture and distribution of innovative immunodiagnostic
systems and assays for the global laboratory market. By utilizing its
specialized expertise in antibody specificity technology, Binding Site has
developed a broad menu of special protein assays, including the Freelite®
test, the only FDA cleared and guideline-recommended serum free light chain
assay on the market. Binding Site gives clinicians and laboratory staff the
tools to significantly improve diagnosis and management of those patients
with specific cancers and immune disorders.

About Datawatch Corporation

Datawatch Corporation(NASDAQ-CM:DWCH) enables ordinary users to deliver
extraordinary results with all their data. Only Datawatch can unlock data
from the widest variety of sources and prepare it for use with visualization
tools or other business processes. When real-time visibility to rapidly
changing data is critical, Datawatch enables you to visualize streaming data
for the most demanding business environments such as capital markets.
Organizations of every size worldwide use Datawatch products including 93 of
the Fortune 100. Datawatch is headquartered in Bedford, Massachusetts with
offices in New York, London, Frankfurt, Stockholm, Singapore, and Manila, and
with partners and customers in more than 100 countries worldwide. See how
Datawatch can help you by downloading a free version

Safe Harbor Statement under the Private Securities Litigation Reform Act of

Any statements contained in this press release that do not describe historical
facts may constitute forward-looking statements as that term is defined in
the Private Securities Litigation Reform Act of 1995. Any such statements
contained herein, including but not limited to those relating to product
performance and viability, are based on current expectations, but are subject
to a number of risks and uncertainties that may cause actual results to
differ materially from expectations. The factors that could cause actual
future results to differ materially from current expectations include the
following: rapid technological change; Datawatch's dependence on the
introduction of new products and product enhancements and possible delays in
those introductions; acceptance of new products by the market, competition in
the software industry generally, and in the markets for next generation
analytics in particular; and Datawatch's dependence on its principal
products, proprietary software technology and software licensed from third
parties. Further information on factors that could cause actual results to
differ from those anticipated is detailed in various publicly-available
documents, which include, but are not limited to, filings made by Datawatch
from time to time with the Securities and Exchange Commission, including but
not limited to, those appearing in the Company's Annual Report on Form 10-K
for the year ended September 30, 2015. Any forward-looking statements should
be considered in light of those factors.

© 2016 Datawatch Corporation. Datawatch and the Datawatch logo are trademarks
or registered trademarks of Datawatch Corporation in the United States and/or
other countries. All other names are trademarks or registered trademarks of
their respective companies.
Investor Contact:

Datawatch Investor Relations
Phone: (978) 441-2200 ext. 8323

Media Contact:
Sarah Bernardi
Datawatch Corporation
Phone: (978) 441-2200 ext. 8387
Twitter: @datawatch


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Datawatch Corporation via Globenewswire


Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.